Bausch & Lomb

Bristol-Myers Squibb appoints three new independent directors

Tuesday, February 21, 2017

Bristol-Myers Squibb has appointed Robert J. Bertolini, Matthew W. Emmens and Theodore R. Samuels to its board of directors, effective immediately. In connection with these appointments, the board will temporarily expand to 14 directors until the 2017 Annual Meeting, to be held on May 2, 2017. Only 11 directors will stand for election at the meeting. Bristol-Myers Squibb also announced that it has entered into an accelerated share repurchase (ASR) program to repurchase, in aggregate, $2 billion of Bristol-Myers Squibb’s common stock.

[Read More]

Eric Morrie joins ClinCapture as director, Product Operations

Monday, April 11, 2016

Eric Morrie joins ClinCapture as director of Product Operations, bringing with him 20 years of experience in the clinical trial industry, including at some of the world’s leading pharmaceutical and medical device companies. The new addition to the executive management team brings ClinCapture’s experience and skill set to a new level.

[Read More]